InChI=1S/C37H49NO5/c1- 20(2) 12- 13- 22- 10- 9- 11- 25- 28(22) 24- 19- 23- 14- 17- 36(39) 34(7,35(23,8) 30(24) 38- 25) 16- 15- 26- 37(36) 32(43- 37) 29- 31(40- 26) 33(5,6) 42- 27(41- 29) 18- 21(3) 4/h9- 12,18,23,26- 27,29,31- 32,38- 39H,13- 17,19H2,1- 8H3/t23- ,26- ,27- ,29+,31- ,32+,34+,35+,36- ,37- /m0/s1 |
LLRYILBJBZFIRA-YPNCZJMTSA-N |
[H] [C@@] 12CC[C@] 3(O) [C@] (C) (CC[C@] 4([H] ) O[C@@] 5([H] ) [C@@] ([H] ) (O[C@@H] (OC5(C) C) C=C(C) C) [C@@] 5([H] ) O[C@@] 345) [C@@] 1(C) c1[nH] c3cccc(CC=C(C) C) c3c1C2 |
|
Albophoma yamanashiensis
(IF:412380)
|
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
An EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the action of acyl-CoA:cholesterol acyltransferase (EC 2.3.1.26).
|
|
View more via ChEBI Ontology
(3S,4aR,4bR,5aS,5bS,7aS,13bS,13cR,15aS,16aS)- 1,1,13b,13c- tetramethyl- 9- (3- methylbut- 2- en- 1- yl)- 3- (2- methylprop- 1- en- 1- yl)- 1,4a,4b,6,7,7a,8,13,13b,13c,14,15,15a,16a- tetradecahydro- 5bH- [1,3]dioxino[5'',4'':2',3']oxireno[4',4a']chromeno[5',6':6,7]indeno[1,2- b]indol- 5b- ol
|
7401070
|
Reaxys Registry Number
|
Reaxys
|
7592023
|
PubMed citation
|
Europe PMC
|
|